NPPA panel fixes retail price of spray containing Diclofenac, Methyl Salicylate, Menthol, Details

Written by Dr. Divya Colin Published On 2022-02-11T16:30:02+05:30 | Updated On 11 Feb 2022 4:30 PM IST

NPPA panel fixes retail price of spray containing Diclofenac, Methyl Salicylate, Menthol, Details

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of Spray containing Diclofenac Diethylamine IP 2.32%, Methyl Salicylate IP 10%, Menthol IP 5% manufactured by Pontika Aerotech and marketed by Intas Pharmaceuticals.

The retail price of each of spray containing Diclofenac Diethylamine I P 2.32% w/ w (eq. to Diclofenac Sodium 2% w/w) plus Methyl Salicylate IP 1 0.00 % w/w plus Menthol IP 5.0 % w/w for Pontika Aerotech (manufacturer) and lntas Pharmaceuticals (marketer) has been set at Rs 2.93 per gm excluding GST.

This recommendation came during the 38th meeting of the 'Multidisciplinary Committee of Experts' meeting, held on January 24, 2022, under the convenorship of Dr. Vinod Kotwal, Member Secretary, through video-conferencing.

The issue of retail price fixation of Spray containing Diclofenac Diethylamine IP 2.32%, Methyl Salicylate IP 10%, Menthol IP 5% manufactured by Pontika Aerotech and marketed Intas Pharmaceutical under Para 5 of DPCO 2013 was analyzed at the meeting.

Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID). NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac Diethylamine is used to relieve pain and inflammation associated with musculoskeletal disorders, strain, sprain, arthritis, and low back pain.

Also Read:NPPA seeks clarification on license status from Clotrimazole mouth paint manufacturers

Methyl salicylate is a topical counter-irritant used for the symptomatic relief of acute musculoskeletal pain in the muscles, joints, and tendons. Menthol is an organic compound used to treat mild to moderate muscle and joint pain.

At a recent Multidisciplinary Committee of Experts meeting, the panel noted that the retail price of the subject formulation has been given to various companies and the companies have submitted the form-V data to NPPA.

Based on Form V data the committee decided to recommend the retail price of spray containing Diclofenac Diethylamine IP 2.32%, Methyl Salicylate IP 10%, Menthol IP 5% manufactured by Pontika Aerotech and marketed by Intas Pharmaceutical.

Accordingly, the committee recommended the retail price of the spray containing Diclofenac Diethylamine IP 2.32%, Methyl Salicylate IP 10%, Menthol IP 5% manufactured by Pontika Aerotech and marketed by Intas Pharmaceutical at Rs 2.93 per gm excluding GST, as detailed below.

S. No .	Company	Unit	PTR	PTR per gm
1.	M/ s Sun Pharmaceutical Industries Ltd. (as per Form-V data)	55gm	139.29	Rs. 2.53
2.	!Add: Retailer margin @16% (16% ofs l. No. 1 )			Rs. 0.40
3.	Pro posed Retail Price based on submitted Form-V by the companies (excluding GST) (sl. No . 1+ sl. No. 2)			Rs. 2.93 (Retail price per gm ex. GST)
4.	Retail price claimed			Rs. 6.36 per gm excluding GST
5.	Recommended retail price			Rs. 2.93 per gm excluding GST

Also Read:NPPA panel fixes retail price of Diclofenac transdermal patch marketed by Hetero Healthcare

nppadiclofenac diethylaminemethyl salicylatementholretail pricenational pharmaceutical pricing authority

Dr. Divya Colin

Doctor of Pharmacy

Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.